Venolayf gel 100g

Description

Composition
Active substance:
100 g of gel contains: troxerutin in terms of 100% substance – 2 g sodium heparin, calculated on the dry matter – 0.25 g (30000ME), dexpanthenol in terms of 100% substance – 5 g ;.
Excipients:
Phenylethanol 1 g, 10 g of propylene glycol, carbomer 940 or 980, 0.8 g, Trometamol 0.4 g, purified water 100 g
Description:
Clear or almost clear gel is light yellow color with a specific smell.
Product form:
Gel for external use 0.25% + 5% + 2%. 40 or 100 g in a tube of aluminum. Each tube together with instructions for use in a stack of cardboard.
Contraindications
Increased sensitivity to the drug; open infected wounds or wounds with copious exudation at the site of application; Children under 1 year.
Indications
Edematous pain and mikrotsirkuljatorno-trophic disorders caused by lower limb venous insufficiency (varicose veins, acute and chronic thrombophlebitis, post-trombophlebitic syndrome, chronic lymphostasis); soft tissue injury (hematomas, sprains, strains); for acceleration of granulation and epithelization trophic ulcers in the regeneration phase (expressed in the absence of exudation).
Interaction with other drugs
Drug interactions with other drugs is not revealed.
Overdose
Overdosing is unlikely due to the low systemic absorption of the gel components.
pharmachologic effect
Pharmacological group:
Anticoagulant means of direct action for local application + other drugs.
Pharmacodynamics:
Venolayf® gel – a combined preparation for external use,
pharmacological properties which are caused by the action of substances within the egosostav. Heparin – direct anticoagulant, natural protivosvertyvayuschiyfaktor body – has anti-inflammatory action, promotes the regeneration of connective tissue due to inhibition of hyaluronidase activity; prevents thrombosis, activates the fibrinolytic properties of blood; improve local blood flow. Dexpanthenol – provitamin B5 – the skin is transformed into pantothenic acid,
included in the composition of coenzyme A, which plays an important role in the processes of acetylation and oxidation; improving metabolic processes, dexpanthenol promotes regeneration of damaged tissues; improves absorption of heparin. Troxerutin – angioprotective means; has a P-vitamin activity (tissue reduces vascular permeability and capillary fragility), helps to normalize microcirculation and tissue trophism reduces stagnation in the veins and tissues paravenoznyh; It has antiexudative and antiinflammatory action.
Pharmacokinetics:
When applied topically active substances quickly absorbed by the skin. Heparin is stored in the upper layers and actively binds to skin proteins, dexpanthenol penetrates all layers of the skin and converted into pantothenic acid, troxerutin 30 minutes found in the dermis, and after 2-5 hours in the subcutaneous adipose tissue.
Pregnancy and breast-feeding
Perhaps the use of the drug Venolayf® during pregnancy and lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
There are local manifestations of allergic reactions (rash, pruritus).
special instructions
Venolayf® not intended for ophthalmic use, for intravaginal and rectal administration.
Storage conditions
At a temperature of 15 to 25 C. Keep out of reach of children.
Dosing and Administration
Outwardly. Apply a thin layer to the affected area 2-3 times a day,
uniformly distributing on the skin surface light rubbing dvizheniyamido completely absorbed. The course of treatment is 2-3 weeks. Neobhodimostdalneyshego treatment determined by the attending physician according to the severity of the pathological process and clinical test results. 2-3 times per year, with a relapse of the disease, treatment can be carried out. When trophic ulcers with slight exudation before using the product is purified from the wound surface exudate and necrotic tissue, if necessary washed with a solution of 3% hydrogen peroxide, nitrofural 1: 5000 or bigluconate 0.05% chlorhexidine and dried. The gel is applied evenly a thin layer so that the entire affected surface was covered drug and a sterile gauze bandage applied. Changing dressings spend 1 time per day. In the open method of treatment preparation is applied 1-2 times per day. The duration of treatment is determined by the dynamics of epithelialization.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist